Divi's Laboratories Ltd

NSE: DIVISLAB · BSE: 532488 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹9,588.00
Market cap: ₹2,54,531 Cr
Revenue (annual): ₹10,560 Cr
Net profit (annual): ₹2,568 Cr
P/E (TTM): 87.0×Sector 47.4×
Promoter holding: 51.88%+0.00% QoQ
FII holding: 20.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 3 Promoter Selling 2 Earnings Call 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Dividend 1 Capital Structure Change 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Jul 2026 17:41 IST BSE

Business Update

Divi's Laboratories Business Update

Divi’s Laboratories submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and sustainability initiatives.

Read the filing ↗